Sabbah Muhammad, Engstrøm Thomas, De Backer Ole, Søndergaard Lars, Lønborg Jacob
Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Front Cardiovasc Med. 2021 May 21;8:654892. doi: 10.3389/fcvm.2021.654892. eCollection 2021.
Transcutaneous aortic valve implantation (TAVI) has led to a paradigm shift in the treatment of severe aortic stenosis (AS) in the elderly and is expanding to still younger and lower-risk patients with severe AS as an alternative to surgical aortic valve replacement (SAVR). While the role of coronary artery bypass grafting with SAVR is well-documented, the analog of percutaneous coronary intervention with TAVI is less so. The aim of this review is to provide an overview of the important challenges in treating severe AS and co-existing coronary artery disease in patients planned for TAVI.
经皮主动脉瓣植入术(TAVI)已使老年重度主动脉瓣狭窄(AS)的治疗模式发生了转变,并且正在扩展至年龄更小、风险更低的重度AS患者,作为外科主动脉瓣置换术(SAVR)的替代方案。虽然冠状动脉旁路移植术联合SAVR的作用已有充分记录,但TAVI的经皮冠状动脉介入类似物的情况却并非如此。本综述的目的是概述计划接受TAVI治疗的重度AS合并冠状动脉疾病患者在治疗中面临的重要挑战。